Showing 1 - 8 results of 8 for search 'Amr Shaaban Hanafy', query time: 0.03s Refine Results
  1. 1
    The Additive Effect of Platelet-Rich Plasma in the Treatment of Actively Bleeding Peptic Ulcer

    The Additive Effect of Platelet-Rich Plasma in the Treatment of Actively Bleeding Peptic Ulcer by Waseem M. Seleem, Amr Shaaban Hanafy

    Published 2021-11-01
    Get full text
    Article
  2. 2
    Efficacy of argon plasma coagulation in the management of portal hypertensive gastropathy

    Efficacy of argon plasma coagulation in the management of portal hypertensive gastropathy by Amr Shaaban Hanafy, Amr Talaat El Hawary

    Published 2016-10-01
    Get full text
    Article
  3. 3
    Predictors of Fibrosis Progression in Chronic Active Hepatitis C Related Nephropathy

    Predictors of Fibrosis Progression in Chronic Active Hepatitis C Related Nephropathy by Amr Shaaban Hanafy, Emad Eldin Shaaban, Sheren Al Zahaby

    Published 2019-05-01
    Get full text
    Article
  4. 4
    Multifocal fatty liver disease, insulin resistance and carotid atherosclerosis: exploring the interrelated relationship

    Multifocal fatty liver disease, insulin resistance and carotid atherosclerosis: exploring the interrelated relationship by Amr Shaaban Hanafy, Sherief Abd-Elsalam, Ayman F. Ahmed, Mohammed M. Dawoud

    Published 2018-12-01
    Get full text
    Article
  5. 5
    Mac-2 binding protein glycosylation isomer as a potential biomarker of hepatocellular carcinoma in HCV-cured patients

    Mac-2 binding protein glycosylation isomer as a potential biomarker of hepatocellular carcinoma in HCV-cured patients by Amr Shaaban Hanafy, Khalid Ali Muftah Abdelaziz, Fedaa Nabil Mohammad, Amr Samir Ibrahim

    Published 2024-11-01
    Get full text
    Article
  6. 6
    Predictors of residual hepatic reserve and hepatic decompensation in cirrhotic patients after ablated hepatocellular carcinoma treated by DDAs or systemic therapy

    Predictors of residual hepatic reserve and hepatic decompensation in cirrhotic patients after ablated hepatocellular carcinoma treated by DDAs or systemic therapy by Amr Shaaban Hanafy, Mohamed Sorour Mohamed, Mohamed Abu Taleb, H. M. Mohammed, Tarek M. H. Ibrahim, Sameh Saber, Hesham A. Atia

    Published 2021-10-01
    Get full text
    Article
  7. 7
    Randomized Controlled Study Comparing Use of Propofol Plus Fentanyl versus Midazolam Plus Fentanyl as Sedation in Diagnostic Endoscopy in Patients with Advanced Liver Disease

    Randomized Controlled Study Comparing Use of Propofol Plus Fentanyl versus Midazolam Plus Fentanyl as Sedation in Diagnostic Endoscopy in Patients with Advanced Liver Disease by Sameh Abdelkhalik Ahmed, Amal Selim, Nehad Hawash, Ahmed Khaled Tawfik, Mohamed Yousef, Abdelrahman Kobtan, Rehab Badawi, Sally Elnawasany, Reham Abdelkader Elkhouly, Amr Shaaban Hanafy, Fatma H. Rizk, Loai Mansour, Sherief Abd-Elsalam

    Published 2017-01-01
    Get full text
    Article
  8. 8
    Prognostic impact of age on outcomes of hepatic decompensation in patients with compensated cirrhosis (CHESS2102): an international, multicenter cohort study

    Prognostic impact of age on outcomes of hepatic decompensation in patients with compensated cirrhosis (CHESS2102): an international, multicenter cohort study by Shanghao Liu, Jia Li, Yujun Wong, Hyung Joon Yim, Masashi Hirooka, Hirayuki Enomoto, Qing Xie, Erhei Dai, Amr Shaaban Hanafy, Zhujun Cao, Lili Zhao, Kok Ban Teh, Tae Hyung Kim, Young Kul Jung, Yohei Koizumi, Yoichi Hiasa, Takashi Nishimura, Hiroko Iijima, Qingyi Tian, Xinru Guo, Yansheng Jia, Jinfang Sun, Chuan Liu, Xiaolong Qi

    Published 2024-11-01
    Get full text
    Article

Search Tools: